Bio-Techne (TECH) Share-based Compensation Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.92% |
| Dec 31, 2025 | -49.75% |
| Sep 30, 2025 | -2.04% |
| Jun 30, 2025 | -5.44% |
| Mar 31, 2025 | -45.19% |
| Dec 31, 2024 | 7.49% |
| Sep 30, 2024 | 2.96% |
| Jun 30, 2024 | -2.77% |
| Mar 31, 2024 | 7.19% |
| Dec 31, 2023 | -46.59% |
| Sep 30, 2023 | -2.69% |
| Jun 30, 2023 | -16.46% |
| Mar 31, 2023 | -46.82% |
| Dec 31, 2022 | 26.51% |
| Sep 30, 2022 | 30.68% |
| Jun 30, 2022 | 19.76% |
| Mar 31, 2022 | 17.91% |
| Dec 31, 2021 | -37.22% |
| Sep 30, 2021 | 29.76% |
| Jun 30, 2021 | 35.70% |
| Mar 31, 2021 | -29.62% |
| Dec 31, 2020 | 46.38% |
| Sep 30, 2020 | 44.75% |
| Jun 30, 2020 | 37.33% |
| Mar 31, 2020 | 44.41% |
| Dec 31, 2019 | 38.61% |
| Sep 30, 2019 | 45.23% |
| Jun 30, 2019 | 55.71% |
| Mar 31, 2019 | 52.24% |
| Dec 31, 2018 | 39.63% |
| Sep 30, 2018 | 82.64% |
| Jun 30, 2018 | 97.31% |
| Mar 31, 2018 | 75.04% |
| Dec 31, 2017 | 44.82% |
| Sep 30, 2017 | 65.79% |
| Jun 30, 2017 | 68.39% |
| Mar 31, 2017 | 75.16% |
| Dec 31, 2016 | 36.73% |
| Sep 30, 2016 | 61.54% |
| Jun 30, 2016 | 68.79% |
| Mar 31, 2016 | 92.79% |
| Dec 31, 2015 | 26.59% |
| Sep 30, 2015 | 71.84% |
| Jun 30, 2015 | 47.75% |
| Mar 31, 2015 | 73.89% |
| Dec 31, 2014 | 21.71% |
| Sep 30, 2014 | 67.93% |